Multiple Myeloma Bone Disease: How Novel Agents Are Changing Treatment
Explore how novel agents like romosuzumab and anti-DKK1 therapies are changing the landscape of multiple myeloma bone disease treatment beyond standard bisphosphonates.
- Jun, 20 2026
- 0 Comments